News Focus
News Focus
icon url

crescentmotor

01/04/25 10:33 PM

#478917 RE: Hoskuld #478910

Seems like a lot of silly effort for no impact on share price come Monday-Friday.



With AVXL's MAA being accepted and under review, a favorable/supportive peer review article about to be officially released in mass distribution, and presentations of OLE trial data at the prestigious JPM annual conference in mid January, my bet is that a rising AVXL stock share price as we move through 2025 is going to relegate the FUDsters into nothing more than a slight nuisance. Institutions will replace most of the retail shareholders and higher AVXL stock prices will not barrier to execution. The real show hasn't even started yet--enjoy!
icon url

frrol

01/04/25 10:42 PM

#478922 RE: Hoskuld #478910

How many "world class"? Be wary of confirmation bias. And there's no reason to be afraid of investors. You'll be alright.
icon url

Investor2014

01/05/25 2:09 AM

#478945 RE: Hoskuld #478910

The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
icon url

LakeshoreLeo1953

01/05/25 8:49 AM

#478958 RE: Hoskuld #478910

58 world-class neurologists



On its face I doubt that is correct, but
Since I cannot be bothered documenting each

How are site clinicians world class?